<div id="container" class="bg4"> 
  
  <!--menu top-->
   <div id="menu_top"></div>
  <!--end menu top-->
  
  <div class="titleTL">
    <i18n id="v21_titleTL">Komplementsystem
</i18n>
  </div>
  <!--end .titleTL--> 
  
  <!--elements-->
  <div class="btn_lib"></div>
  <div class="btn_ref"></div>
  <div class="btn_plus"></div>
  <!--end elements-->
  
  <div id="main_container">
    <div class="bnt1_congsc4"></div>
    <div class="bnt2_congsc4"></div>
    <div class="zoom_outsc4"></div>
    <div class="btn_cong1"></div>
    <div class="btn_cong2"></div>
    <div class="screen_1">
      <div class="board">
        <div class="title_board tradegothicltstd_bd2 white"><i18n id="v21_title_board">
Ein genetisch bedingter Mangel an Komplementinhibitoren führt zur chronischen, unkontrollierten Komplementaktivierung<sup>(15,16,27)</sup>
        </i18n></div>
      </div>
      <div class="color_bg"></div>
      <div class="three_box"></div>
      <div class="arrow"></div>
      <div class="box_red"></div>
      <div class="box_blue"></div>
      <div class="box_bluelong"></div>
      <div class="box_blueshort"></div>
      <div class="arrow_around"></div>
      <div class="boxblue"></div>
      <div class="boxred"></div>
      <div class="box_note1"></div>
      <div class="box_note2"></div>
      <div class="z1"></div>
      <div class="z2"></div>
      <div class="zoom"></div>
      <div class="txt_three_box1 tradegothicltstd_bd2 grey_dark">
        <i18n id="v21_txt_three_box1">Lektin-Weg</i18n>
      </div>
      <div class="txt_three_box2 tradegothicltstd_bd2 grey_dark">
        <i18n id="v21_txt_three_box2">Klassischer Weg</i18n>
      </div>
      <div class="txt_three_box3 tradegothicltstd_bd2 grey_dark">
        <i18n id="v21_txt_three_box3">Alternativer Weg</i18n>
      </div>
      <div class="c3 tradegothicltstd_bd2 white">
        <i18n id="v21_c3">C3</i18n>
      </div>
      <div class="c5 tradegothicltstd_bd2 white">
        <i18n id="v21_c5">C5</i18n>
      </div>
      <div class="txt_box_bluelong tradegothicltstd_bd2 grey_dark"><i18n id="v21_txt_box_bluelong">
          Immunkomplex Clearance<br>
          Mikrobielle Opsonisierung
      </i18n></div>
      <div class="txt_around tradegothicltstd_bd2 grey_dark">
        <i18n id="v21_txt_around">Amplifikation</i18n>
      </div>
      <div  class="txt_boxblueshort tradegothicltstd_bd2 grey_dark">
        <i18n id="v21_txt_boxblueshort">Komplement-Inhibitoren</i18n>
      </div>
      <div class="txt_boxblue tradegothicltstd_bd2 white">
        <i18n id="v21_txt_boxblue">Proximales Komplement</i18n>
      </div>
      <div class="txt_boxred tradegothicltstd_bd2 white">
        <i18n id="v21_txt_boxred">Terminales Komplement</i18n>
      </div>
      <div class="txt_boxnote1 tradegothicltstd_bd2 grey_dark"><i18n id="v21_txt_boxnote1">
          Potentes Anaphylatoxin<br>
          Chemotaxis<br>
          Proinflammatorisch<br>
          Plättchenaktivierung<br>
          Prothrombotisch
      </i18n></div>
      <div class="txt_boxnote2 tradegothicltstd_bd2 grey_dark"><i18n id="v21_txt_boxnote2">
         Zell-Lyse<br>
          Proinflammatorisch<br>
          Plättchenaktivierung<br>
          Endotheliale Aktivierung<br>
          Prothrombotisch<br>
      </i18n></div>
      <div class="txt1_boxnote tradegothicltstd_bd2 white">
        <i18n id="v21_txt1_boxnote">C5a</i18n>
      </div>
      <div class="txt2_boxnote tradegothicltstd_bd2 white">
        <i18n id="v21_txt2_boxnote">C5b-9<br>
          Terminaler<br>Komplementkomplex</i18n>
      </div>
    </div>
    <div class="screen_2">
      <div class="box_note3">
        <div class="t3_sc2 tradegothicltstd_bd2 white">
          <i18n id="v21_t3_sc2">Konzequenzen</i18n>
        </div>
        <div class="txt1_sc2 tradegothicltstd_bd2"><i18n id="v21_txt1_sc2">
            Anaphylaxe<br>
           Entzündung<br>
            Thrombose
        </i18n></div>
      </div>
      <div class="box_note4">
        <div class="t4_sc2 tradegothicltstd_bd2 white">
          <i18n id="v21_box_note4">Konzequenzen</i18n>
        </div>
        <div class="txt2_sc2 tradegothicltstd_bd2"><i18n id="v21_txt2_sc2">
            Hämolyse<br>
            Entzündung<br>
            Thrombose
        </i18n></div>
      </div>
      <div class="red_right_arrow"><i18n id="right_arrow_text">KONSEQUENZEN</i18n></div>
      <div class="red_left_arrow"><i18n id="left_arrow_text">KONSEQUENZEN</i18n></div>
    </div>
    <div class="screen_3">
      <div class="color_bg_sc3"></div>
      <div class="box_3_big"></div>
      <div class="arrow_big"></div>
      <div class="box_number"></div>
      <div class="box_longblue_big"></div>
      <div class="box_shortblue_big"></div>
      <div class="arrow_big_around"></div>
      <div class="zoom_out"></div>
      <div class="txt_3_big_a tradegothicltstd_bd2">
        <i18n id="v21_txt_3_big_a">Lektin-Weg</i18n>
      </div>
      <div class="txt_3_big_b tradegothicltstd_bd2">
        <i18n id="v21_txt_3_big_b">Klassischer Weg</i18n>
      </div>
      <div class="txt_3_big_c tradegothicltstd_bd2">
        <i18n id="v21_txt_3_big_c">Alternativer Weg</i18n>
      </div>
      <div class="c3_big tradegothicltstd_bd2 white">
        <i18n id="v21_c3_big">C3</i18n>
      </div>
      <div class="txt_bluelong_box tradegothicltstd_bd2"><i18n id="v21_txt_bluelong_box">
          Immunkomplex Clearance<br>
          Mikrobielle Opsonisierung
      </i18n></div>
      <div class="txt_blueshort_box tradegothicltstd_bd2">
        <i18n id="v21_txt_blueshort_box">Komplement-Inhibitoren</i18n>
      </div>
      <div class="txt_arrow_big tradegothicltstd_bd2">
        <i18n id="v21_txt_arrow_big">Amplifikation</i18n>
      </div>
    </div>
    <div class="screen_4">
      <div class="color_bg_sc4"></div>
      <div class="arrow_sc4"></div>
      <div class="boxred_sc4"></div>
      <div class="box_sc4"></div>
      <div class="c5_sc4 tradegothicltstd_bd2 white">
        <i18n id="v21_c5_sc4">C5</i18n>
      </div>
      <div class="txt1_boxnote_cs4 tradegothicltstd_bd2"><i18n id="v21_txt1_boxnote_cs4">
          Potentes Anaphylatoxin<br>
          Chemotaxis<br>
          Proinflammatorisch<br>
          Endotheliale Aktivierung<br>
          Prothrombotisch
      </i18n></div>
      <div class="txt2_boxnote_cs4 tradegothicltstd_bd2 "><i18n id="v21_txt2_boxnote_cs4">
         Zell-Lyse<br>
          Proinflammatorisch<br>
          Plättchenaktivierung<br>
          Endotheliale Aktivierung<br>
          Prothrombotisch<br>
      </i18n></div>
      <div class="c5a tradegothicltstd_bd2 white">
        <i18n id="v21_c5a">C5a</i18n>
      </div>
      <div class="test_box2 tradegothicltstd_bd2 white">
        <i18n id="v21_test_box2">C5b-9<br>
          Terminaler<br>Komplementkomplex</i18n>
      </div>
    </div>
    <div class="screen_5">
      <div class="box1_sc5">
        <div class="txt1_box_sc5 tradegothicltstd_bd2 white">
          <i18n id="v21_txt1_box_sc5">Konsequenzen</i18n>
        </div>
        <div class="txt3_box_sc5 tradegothicltstd_bd2"><i18n id="v21_txt3_box_sc5">
            Anaphylaxe<br>
           Entzündung<br>
            Thrombose
        </i18n></div>
      </div>
      <div class="box2_sc5">
        <div class="txt2_box_sc5 tradegothicltstd_bd2 white">
          <i18n id="v21_txt2_box_sc5">Konsequenzen</i18n>
        </div>
        <div class="txt4_box_sc5 tradegothicltstd_bd2"><i18n id="v21_txt4_box_sc5">
            Hämolyse<br>
            Entzündung<br>
            Thrombose
        </i18n></div>
      </div>
      <div class="arrow1_sc5"></div>
      <div class="arrow2_sc5"></div>
    </div>
  </div>
  <!--End #main_container -->
  <div class="pu">
    <div class="board_pu">
      <div class="txt_pu tradegothicltstd_bd2">
        <ul class="pu_list">
          <li><i18n id="v21_txt1_pu">Das Komplementsystem ist bei gesunden Menschen permanent aktiviert, um eine schnelle Immunantwort zu gewährleisten<sup>(2,15)</sup></i18n></li>
          <li><i18n id="v21_txt2_pu">Komplementinhibitoren kontrollieren die Aktivität des Komplementsystems<sup>(2,15)</sup></i18n></li>
          <li><i18n id="v21_txt3_pu">Beim aHUS liegt ein genetisch bedingter Mangel an Komplementinhibitoren vor<sup>(1)</sup></i18n></li>
          <li><i18n id="v21_txt4_pu">Der Mangel an Komplementinhibitoren führt zu einer permanenten, unkontrollierten Aktivierung des Komplementsystems, was kontinuierlich zunehmende Schäden zur Folge hat<sup>(24)</sup></i18n></li>
          <li><i18n id="v21_tx5t_pu">Eine Genmutation kann bei 30% bis 50% der aHUS-Patienten nicht nachgewiesen werden<sup>(1)</sup></i18n></li>
        </ul>
      </div> 
      <div class="btn_back"></div>     
    </div>
  </div>
  <div class="claim_2line"><i18n id="v21_claim_2line">
 Eine chronische, unkontrollierte Komplementaktivierung führt zu Thrombotischen Mikroangiopathien<sup>(1-3)</sup>
  </i18n></div><!--end .claim_1line-->
  
  <div class="lg_alexion"></div>
  
  <!--Ref-->
  <div class="ref_warpper bg_ref">
    <h1>
      <i18n id="v21_refernces">REFERENZEN</i18n>
    </h1>
    <div class="inner_wapper" >
      <div class="scroller">
        <div class="ref"> <span class="ref_number">
          <i18n id="v21_num_1">1.</i18n>
          </span>
          <i18n id="v21_content_num1">Noris M, Caprioli J, Bresin E et al. Clin J Am Soc Nephrol.  2010; 5: 1844-1859</i18n>
        </div>
        <!--end Ref-->
		  <div class="ref"> <span class="ref_number">
          <i18n id="v21_num_2">2.</i18n></span>
          <i18n id="v21_content_num2">Loirat C, Noris M, Fremeaux-Bacchi V. Pediatr Nephrol. 2008; 23: 1957-1972</i18n>
        </div>
          <div class="ref"> <span class="ref_number">
          <i18n id="v21_num_3">3.</i18n></span>
          <i18n id="v21_content_num3">Fang CJ, Richards A, Liszewski MK, Kavanagh D, Atkinson JP. Br J Haematol. 2008; 143: 336-348</i18n>
        </div>
        <div class="ref"> <span class="ref_number">
          <i18n id="v21_num_9">15.</i18n></span>
          <i18n id="v21_content_num9">Holers VM. Immunol Rev. 2008; 223: 300-316
</i18n>
        </div>
        <div class="ref"> <span class="ref_number">
          <i18n id="v21_num_10">16.</i18n></span>
          <i18n id="v21_content_num10">Noris M, Remuzzi G. N Engl J Med. 2009; 361: 1676-1687</i18n>
        </div>
        <div class="ref"> <span class="ref_number">
          <i18n id="v21_num_11">24.</i18n></span>
          <i18n id="v21_content_num11">Hirt-Minkowski P, Dickenmann M, Schifferli JA. Nephron Clin Pract. 2010; 114: c219-c235
</i18n>
        </div>
           <div class="ref"> <span class="ref_number">
          <i18n id="v21_num_51">27.</i18n></span>
          <i18n id="v21_content_num51">Loirat C, Frémeaux-Bacchi V. Orphanet J Rare Dis. 2011;6:60
</i18n>
        </div>
		 
      </div>
      <!--end Ref--> 
    </div>
    <!--end .scroller-->
    <div class="close"></div>
  </div>
  <!--end .inner_wapper--> 
  
</div>
<!--end ref-->

</div>
<% 
slide.load('css/main.css', 'css/popup.css',
		   'javascript/main.js'); 
%> 